A detailed history of Windsor Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Windsor Capital Management, LLC holds 2,231 shares of ABT stock, worth $226,758. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,231
Previous 2,227 0.18%
Holding current value
$226,758
Previous $245,000 3.27%
% of portfolio
0.08%
Previous 0.08%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

BUY
$109.52 - $120.96 $438 - $483
4 Added 0.18%
2,231 $253,000
Q4 2023

Jan 09, 2024

BUY
$90.19 - $110.4 $270 - $331
3 Added 0.13%
2,227 $245,000
Q3 2023

Oct 04, 2023

BUY
$95.53 - $114.62 $382 - $458
4 Added 0.18%
2,224 $215,000
Q2 2023

Jul 13, 2023

BUY
$100.78 - $112.29 $302 - $336
3 Added 0.14%
2,220 $242,000
Q1 2023

Apr 10, 2023

BUY
$96.86 - $114.01 $290 - $342
3 Added 0.14%
2,217 $224,000
Q4 2022

Jan 13, 2023

BUY
$95.06 - $111.52 $210,462 - $246,905
2,214 New
2,214 $0
Q1 2022

May 04, 2022

SELL
$114.02 - $139.04 $176,731 - $215,512
-1,550 Closed
0 $0
Q4 2021

Feb 07, 2022

BUY
$115.53 - $141.46 $179,071 - $219,263
1,550 New
1,550 $218,000
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $250,352 - $276,962
-2,146 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$105.79 - $124.53 $14,493 - $17,060
137 Added 6.82%
2,146 $248,000
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $1,850 - $2,179
-17 Reduced 0.84%
2,009 $240,000
Q4 2020

Feb 08, 2021

BUY
$105.0 - $114.42 $2,205 - $2,402
21 Added 1.05%
2,026 $221,000
Q3 2020

Oct 09, 2020

BUY
$91.64 - $111.29 $183,738 - $223,136
2,005 New
2,005 $218,000
Q4 2017

Jan 24, 2018

SELL
$53.68 - $57.47 $415,107 - $444,415
-7,733 Closed
0 $0
Q2 2017

Aug 08, 2017

BUY
N/A
7,733
7,733 $375,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $178B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Windsor Capital Management, LLC Portfolio

Follow Windsor Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Windsor Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Windsor Capital Management, LLC with notifications on news.